Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer.
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 2018 10; 67(10):1780-1792.
View in:
PubMed
subject areas
Adenine
Antineoplastic Agents
Cell Line, Tumor
Drug Discovery
Esophageal Neoplasms
Humans
Pharmacogenetics
Pharmacogenomic Testing
Piperidines
Proto-Oncogene Proteins c-myc
Pyrazoles
Pyrimidines
Receptor, ErbB-2
RNA Interference
Signal Transduction
Xenograft Model Antitumor Assays
authors with profiles
Michael Davidson